Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Gritstone bio Announces Preliminary Progression-free SurvivalAand Long-term Circulating Tumor DNA Data From Phase 2 Portion Of Ongoing Phase 2/3 Study Of Personalized Cancer Vaccine, GRANITE, In Front-line Metastatic Microsatellite Stable Colorectal Cancer; Says ' GRANITE was generally well-tolerated with manageable adverse events; no patients have discontinued GRANITE due to adverse events'

Author: Benzinga Newsdesk | April 01, 2024 04:04pm

Posted In: GRTS